Steven A.R. Murphy, MD is a
physician, educator and entrepreneur, influential in
diverse fields from education and health care to
software development and the blogosphere. Dr Murphy
received two undergraduate degrees from the Pennsylvania
State University where he studied genetics and religion.
He went on to receive a medical degree from the New York
Medical College, pursuing externships in medical
genetics at Yale University, Albert Einstein College of
Medicine, and the Mount Sinai School of Medicine during
his medical school training. Dr. Murphy completed an
internship in pediatrics and medical genetics at the
Mount Sinai School of Medicine and continued his
training in Internal Medicine at Yale New Haven Health’s
Greenwich Hospital. Currently his efforts are directed
towards shaping personalized medicine through Helix
Health. Dr. Murphy is extending his training as the
genetics fellow at Yale University until 2010. His plans
include the creation of a training program in Internal
Medicine and Genetics at Yale University School of
Medicine. Currently he serves on the faculty at New York
Medical College as an Instructor in the Department of
Cell Biology and Anatomy. Dr. Murphy is a prominent
blogger in the field of personalized medicine and
genomics and is a consultant to several venture capital
firms.
The creative vision of Helix Health has evolved since
2004 when Dr. Murphy conceived of a genetic testing and
consulting, database, and educational organization that
will help usher in a new era of personalized medicine.
He has dedicated himself to establishing the referral
base for Helix Health, educating colleagues regarding
current genetic technology, and charting the direction
of the company. Dr. Murphy is a member of the American
Society of Human Genetics, the American Academy of
Pediatrics, and the American College of Physicians and
is a charter member of the Physician Genome
Partnership-an organization is dedicated to guiding best
clinical practices in genomics.
Adam J. Messenger, MD received his
medical degree from New York Medical College where he
concomitantly completed his Master of Science degree in
Pharmacology. He received his Bachelor of Science degree
in Neuroscience from Trinity College in Hartford, CT
after serving as a cadet at the United States Coast
Guard Academy. Dr. Messenger completed his residency
training in Internal Medicine at Yale New Haven Health’s
Greenwich Hospital where he served as Chief Resident.
During his residency he continued to actively study and
apply the principles of Pharmacology. Dr. Messenger
recently was appointed to the faculty at New York
Medical College and at the Graduate School of Basic
Medical Sciences in the Department of Pharmacology.
Dr. Messenger has a particular interest in the fields
of Pharmacogenomics and Pharmacogenetics, which strive
to select the correct medication and the correct dosage
of that medication based on an individual’s genetic
blueprint. He and Dr. Murphy met in medical school and
share the vision of personalized medicine provided by
Helix Health. They continue to lecture extensively about
personalized medicine and genetic health topics
throughout the tri-state area.
Matthew B. Lubin, MD is a clinician,
researcher, inventor and educator. Dr. Lubin’s interest
in genetics reaches back to the beginnings of the
recombinant DNA revolution, when he obtained bachelors
degrees in both biochemistry and biology at Brandeis
University. After earning his medical degree at New
Jersey Medical School and training in internal medicine
at University Hospital in Newark, Dr. Lubin completed a
three-year fellowship in medical genetics at UCLA and
Cedars-Sinai Medical Center in Los Angeles. There his
special interest was the genetics of common adult
diseases. He helped establish the Cedars-Sinai GenRISK
program, one of the first programs in the nation to help
patients with family histories of disorders such as
heart disease and breast cancer. Returning to the New
York metropolitan area, Dr. Lubin continued his career
as the Director of Medical Genetics at the Preventive
Medicine Institute/Strang Cancer Prevention Center in
Manhattan. Evaluating literally hundreds of patients
with familial breast cancer at Strang, Dr. Lubin’s
clinical research helped identify BRCA1, the gene which,
when mutated, is most commonly responsible for
hereditary breast and ovarian cancer. In the laboratory
Dr. Lubin was part of a team that developed and
eventually earned a patent for new DNA detection
techniques. Since leaving Strang, Dr. Lubin has been on
the staff of Lenox Hill Hospital while seeing patients
in a private medical genetics practice devoted to common
adult disorders.
Dr. Lubin is proud and excited to join the team at Helix
Health, whose vision for preventive care guided by
family history and genetic information so closely agrees
with the philosophy that he has held for so long.
Jennifer Ibrahim, MD is a Clinical
Geneticist who received her MD degree at UMDNJ-New
Jersey Medical School. She completed her pediatric
residency at Babies Hospital, Columbia College of
Physicians and Surgeons in New York and fellowship
training in clinical genetics in the Department of Human
Genetics of the Mount Sinai School of Medicine. She
currently serves as a clinician at St. Joseph’s Regional
Medical Center Section of Genetics in addition to
working with the Helix Health team. She is a Diplomat of
the American Board of Pediatrics and the American Board
of Medical Genetics. Her specialty interests
include preconception genetics as well as familial
cancer syndromes.
Our Scientific
Advisors
